She underwent six cycles of chemotherapy followed by exploratory laparotomy.<h4>Objective</h4>We examined the precipitating factors, laboratory abnormalities including cancer antigen 125 (CA-125) levels, treatment strategies including neoadjuvant therapy and debulking surgery, and clinical recovery in ovarian malignancy.<h4>Conclusion</h4>Primary debulking surgery (PDS), although the preferred treatment for ovarian cancer, is accompanied by combination chemotherapy based on platinum. The gene discussed is MUC16; the disease is ovarian cancer.